Reference
Naito A, et al. Case Series of the TAS-102 plus Bevacizumab(Bev)Combination Therapy in Unresectable Advanced Colorectal Cancer. Gan to Kagaku Ryoho 47: 2104-2106, No. 13, Dec 2020. Available from: URL: https://pubmed.ncbi.nlm.nih.gov/33468875/ [Japanese; summarised from a translation]
Rights and permissions
About this article
Cite this article
Bevacizumab/tipiracil/trifluridine. Reactions Weekly 1843, 80 (2021). https://doi.org/10.1007/s40278-021-91182-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-91182-z